Both are leaders in robotic-assisted surgery - Intuitive Surgical in soft tissue procedures and Stryker in orthopedic ...

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stryker will release its second-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.

Stryker Corporation SYK reported fourth-quarter 2024 adjusted earnings per share (EPS) of $4.01, which beat the Zacks Consensus Estimate of $3.87 by 3.6%. The bottom line also improved 15.9% year ...

Looking at stock returns, SYK, with 0% returns in the last twelve months, has fared better than ISRG stock, down 20%, and the broader S&P500 index, down 9%.

Buying $100 In SYK: If an investor had bought $100 of SYK stock 10 years ago, it would be worth $395.17 today based on a price of $390.10 for SYK at the time of writing.

Investors in Stryker Corp (Symbol: SYK) saw new options become available today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SYK ...

Investors in Stryker Corp (Symbol: SYK) saw new options begin trading today, for the September 2026 expiration. One of the key data points that goes into the price an option buyer is willing to ...

Spleen tyrosine kinase (SYK) is known to have a crucial role in adaptive immune receptor signalling. However, recent reports indicate that SYK also mediates other, unexpectedly diverse biological ...

Stryker Corporation’s SYK shares closed the trading session at $385.18 on Friday, 5.2% below its 52-week high of $406.19 reached on Jan. 28, 2025. In the past six months, SYK has gained 13%. In ...